We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

89 hedge funds and large institutions have $711M invested in BELLUS Health Inc. in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 7

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

144% more capital invested

Capital invested by funds: $291M → $711M (+$420M)

62% more funds holding

Funds holding: 5589 (+34)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

26% less call options, than puts

Call options by funds: $11.6M | Put options by funds: $15.6M

Holders
89
Holders Change
+34
Holders Change %
+61.82%
% of All Funds
1.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
42
Increased
20
Reduced
19
Closed
7
Calls
$11.6M
Puts
$15.6M
Net Calls
-$3.99M
Net Calls Change
-$8.65M
Name Holding Trade Value Shares
Change
Change in
Stake
MP
26
Mangrove Partners
Connecticut
$7.63M +$6.29M +948,221 New
SAM
27
Sectoral Asset Management
Quebec, Canada
$5.81M -$8.08M -1,216,938 -63%
BlackRock
28
BlackRock
New York
$4.51M +$3.72M +559,813 New
ACP
29
Acuta Capital Partners
California
$4.23M -$9.84M -1,482,500 -74%
JP Morgan Chase
30
JP Morgan Chase
New York
$4.12M -$2.97M -447,761 -47%
AAA
31
Affinity Asset Advisors
New York
$4.03M -$213K -32,030 -6%
GTC
32
Ghost Tree Capital
New York
$3.62M +$332K +50,000 +13%
FAM
33
Fred Alger Management
New York
$3.21M +$2.65M +398,846 New
PVI
34
Pura Vida Investments
New York
$3.12M +$352K +52,992 +16%
AIC
35
AWM Investment Company
New York
$3.06M -$133K -20,000 -5%
JG
36
Jefferies Group
New York
$2.61M +$1.36M +204,679 +171%
SSA
37
Schonfeld Strategic Advisors
New York
$2.55M +$713K +107,377 +51%
Rockefeller Capital Management
38
Rockefeller Capital Management
New York
$2.42M
MIM
39
Monashee Investment Management
Massachusetts
$2.01M +$1.66M +250,000 New
JGC
40
J. Goldman & Co
New York
$1.61M +$1.33M +199,806 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.56M +$864K +130,155 +206%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.5M +$1.23M +185,900 New
Adage Capital Partners
43
Adage Capital Partners
Massachusetts
$1.21M -$1.66M -250,000 -63%
Goldman Sachs
44
Goldman Sachs
New York
$1.16M +$952K +143,521 New
CSS
45
Cubist Systematic Strategies
Connecticut
$985K +$724K +109,152 +826%
SCP
46
Sender Company & Partners
New York
$875K +$721K +108,719 New
ECM
47
ExodusPoint Capital Management
New York
$812K +$670K +100,916 New
AA
48
ALPS Advisors
Colorado
$733K +$605K +91,098 New
FWSM
49
First Wilshire Securities Management
California
$660K
Two Sigma Investments
50
Two Sigma Investments
New York
$619K +$510K +76,900 New

BLU Hedge Fund Activity: Q4 2021 in Review

89 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2021, worth a combined $711M — up 144% from $291M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new BLU positions and 7 closed out — a net gain of 35 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $67.9M. The largest seller was Acuta Capital Partners, cutting an estimated $9.84M.

  • 89 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2021, up from 55 in Q3 2021.
  • Funds reported $711M of BELLUS Health Inc. stock for Q4 2021, up 144% quarter-over-quarter.
  • 42 funds opened new BELLUS Health Inc. positions in Q4 2021 and 7 closed out, a net change of +35 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2021 was RA Capital Management, an estimated $67.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2021 was Acuta Capital Partners, an estimated $9.84M sold.

Based on aggregated 13F filings for Q4 2021.